This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Nov;43(6):744-5.

doi: 10.4103/0253-7613.89847.

Tolerance of bladder antispasmodics in children with urinary incontinence: An observational study from North India

Vishal Bansal¹, Bikash Medhi, Om Prakash, Balbinder Kaur, Kl Narasimhan

Affiliations

PMID: 22144795
PMCID: PMC3229806
DOI: 10.4103/0253-7613.89847

Tolerance of bladder antispasmodics in children with urinary incontinence: An observational study from North India

Vishal Bansal et al. Indian J Pharmacol. 2011 Nov.

. 2011 Nov;43(6):744-5.

doi: 10.4103/0253-7613.89847.

Authors

Vishal Bansal¹, Bikash Medhi, Om Prakash, Balbinder Kaur, Kl Narasimhan

Affiliation

¹ Department of Clinical Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160012, India.

PMID: 22144795
PMCID: PMC3229806
DOI: 10.4103/0253-7613.89847

No abstract available

PubMed Disclaimer

Similar articles

Clinical indications for augmentation in children with neurogenic urinary incontinence following bladder outlet procedures: Results of a 14-year observational study.
Snodgrass W, Granberg C. Snodgrass W, et al. J Pediatr Urol. 2016 Feb;12(1):46.e1-8. doi: 10.1016/j.jpurol.2015.06.018. Epub 2015 Sep 18. J Pediatr Urol. 2016. PMID: 26429598
[Endoscopic management of urinary incontinence in neurogenic bladder due to spinal cord lesions in children].
Dariane C, Peycelon M, Lallemant P, Forin V, Audry G. Dariane C, et al. Prog Urol. 2014 Jan;24(1):39-45. doi: 10.1016/j.purol.2013.05.001. Epub 2013 Jun 12. Prog Urol. 2014. PMID: 24365627 French.
The risk factors for recurrence of febrile urinary tract infection and renal scarring in children with functional urinary incontinence.
Cetin N, Kavaz Tufan A, Tokar B. Cetin N, et al. Low Urin Tract Symptoms. 2021 Jan;13(1):160-167. doi: 10.1111/luts.12349. Epub 2020 Oct 5. Low Urin Tract Symptoms. 2021. PMID: 33016011
Urinary incontinence in children: suggestions for definitions and terminology.
Hjälmås K. Hjälmås K. Scand J Urol Nephrol Suppl. 1992;141:1-6; discussion 18-9. Scand J Urol Nephrol Suppl. 1992. PMID: 1609244 Review.
[Drug therapy of female urinary incontinence].
Flamant G, Gillet JY. Flamant G, et al. Presse Med. 1995 Jan 7;24(1):31-4. Presse Med. 1995. PMID: 7899333 Review. French.

See all similar articles

References

1. [Last accessed on 2010 Dec 12]. Available from: http://www.fda.gov/fdac/features/2005/505_incontinence.html#meds .
1. Siddique MA, Perry CM, Scott LJ. Oxybutynin extended-release: a review of its use in the management of overactive bladder. Drugs. 2004;64:885–912. - PubMed
1. Lee JG, Hong JY, Choo MS, Kwon HY, Chung DY, Lee KS, et al. Tolterodine: as effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder. Int J Urol. 2002;9:247–52. - PubMed
1. Yucel S, Akkaya E, Guntekin E, Kukul E, Danisman A, Akman S, et al. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed? Urology. 2005;65:369–73. - PubMed
1. Bolduc S, Upadhyay J, Payton J, Bägli DJ, McLorie GA, Khoury AE, et al. The use of tolterodine in children after oxybutynin failure. BJU Int. 2003;91:398–401. - PubMed

LinkOut - more resources

Full Text Sources